Biofrontera BFRI Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Stock Rises RYAM Q1 2026 Earnings Significant EPS Miss Overshadowed by Modest Stock Gain JBI Q1 2026 Earnings EPS Falls 89 Short of Estimates as Stock Gains 199 Tenaya Therapeutics Q1 2026 Earnings Narrow Miss on Earnings as Biotech Firm Reports No Revenue Velocity Financial Q1 2026 Earnings EPS Beat Fails to Boost Stock SERV Q1 2026 Earnings PreRevenue Robotics Company Misses EPS Estimates as Losses Widen